Mumbai A division bench of the Delhi High Court on Wednesday ordered Dr Reddy's Labs to file its reply to the injunction petition moved by Danish drug maker Novo Nordisk for its blockbuster weight-loss drug semaglutide, which is sold under the brand name Wegovy.
An expert in intellectual property laws told ET that the order may require Dr Reddy's Labs to explain the grounds for exports of weight-loss drug semaglutide.
The court's directive comes on the back of a plea by Novo Nordisk, which alleged patent infringement. The patent for the weight-loss drug is slated to end in March next year.
An expert in intellectual property laws told ET that the order may require Dr Reddy's Labs to explain the grounds for exports of weight-loss drug semaglutide.
The court's directive comes on the back of a plea by Novo Nordisk, which alleged patent infringement. The patent for the weight-loss drug is slated to end in March next year.
You may also like
Pakistan End Series on High with 74-Run Win; Bangladesh Clinch Series 2-1
The Airtel-Perplexity Blueprint, Ohm Mobility To Shut Down & More
Common fruit 'cuts dangerous cholesterol and makes your heart stronger'
Manipur: President's rule extended for six months; effective from August 13
World's first laser-armed tank that can shoot down drones unveilsed by unlikely Nato ally
